The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology
Open accessAbstract
The European Society of Cardiology (ESC) has published a series of guidelines on heart failure (HF) over the last 25 years, most recently in 2016. Given the amount of new information that has become available since then, the Heart Failure Association (HFA) of the ESC recognized the need to review and summarise recent developments in a consensus document. Here we report from the HFA workshop that was held in January 2019 in Frankfurt, Germany. This expert consensus report is neither a guideline update nor a position statement, but rather a summary and consensus view in the form of consensus recommendations. The report describes how these guidance statements are supported by evidence, it makes some practical comments, and it highlights new research areas and how progress might change the clinical management of HF. We have avoided re-interpretation of information already considered in the 2016 ESC/HFA guidelines. Specific new recommendations have been made based on the evidence from major trials published since 2016, including sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus, MitraClip for functional mitral regurgitation, atrial fibrillation ablation in HF, tafamidis in cardiac transthyretin amyloidosis, rivaroxaban in HF, implantable cardioverter-defibrillators in non-ischaemic HF, and telemedicine for HF. In addition, new trial evidence from smaller trials and updated meta-analyses have given us the chance to provide refined recommendations in selected other areas. Further, new trial evidence is due in many of these areas and others over the next 2 years, in time for the planned 2021 ESC guidelines on the diagnosis and treatment of acute and chronic heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Self-citationEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citationAntiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Self-citationCanagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Self-citationDapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Self-citationEmpagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806640 · Cited by 3,017
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
Authors/Task Force Members, Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn309 · Cited by 2,696
Self-citationCatheter Ablation for Atrial Fibrillation with Heart Failure
Marrouche, N. F., Brachmann, J., Andresen, D., Siebels, J., Boersma, L., Jordaens, L., Merkely, B., Pokushalov, E., Sanders, P., Proff, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1707855 · Cited by 2,492
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
Swedberg, K., Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., Tavazzi, L., Smiseth, O. A., Gavazzi, A., Haverich, A., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi204 · Cited by 2,260
Self-citationFerric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908355 · Cited by 2,083
Self-citationNonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Gillmore, J. D., Maurer, M. S., Falk, R. H., Merlini, G., Damy, T., Dispenzieri, A., Wechalekar, A. D., Berk, J. L., Quarta, C. C., Grogan, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021612 · Cited by 2,081
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya, A., de Lange, F. J., Deharo, J.-C., Elliott, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martín, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy037 · Cited by 1,951
Self-citationPercutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation
Obadia, J.-F., Messika-Zeitoun, D., Leurent, G., Iung, B., Bonnet, G., Piriou, N., Lefèvre, T., Piot, C., Rouleau, F., Carrié, D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805374 · Cited by 1,806
Defibrillator implantation in patients with nonischemic systolic heart failure
Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1608029 · Cited by 1,763
Guidelines for the diagnosis and treatment of chronic heart failure
Remme, W. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2783 · Cited by 1,592
Packer, D. L., Mark, D. B., Robb, R. A., Monahan, K. H., Bahnson, T. D., Poole, J. E., Noseworthy, P. A., Rosenberg, Y. D., Jeffries, N., Mitchell, L. B., et al. (2019) · JAMA · doi:10.1001/jama.2019.0693 · Cited by 1,503
Ridker, P. M., MacFadyen, J. G., Thuren, T., Everett, B. M., Libby, P., Glynn, R. J., Ridker, P., Lorenzatti, A., Krum, H., Varigos, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32247-x · Cited by 1,344
Self-citationAngiotensin-neprilysin inhibition in acute decompensated heart failure
Velazquez, E. J., Morrow, D. A., DeVore, A. D., Duffy, C. I., Ambrosy, A. P., McCague, K., Rocha, R., & Braunwald, E. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812851 · Cited by 1,260
Ponikowski, P., van Veldhuisen, D. J., Comin-Colet, J., Ertl, G., Komajda, M., Mareev, V., McDonagh, T., Parkhomenko, A., Tavazzi, L., Levesque, V., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu385 · Cited by 1,242
Self-citationWild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
González-López, E., Gallego-Delgado, M., Guzzo-Merello, G., de Haro-del Moral, F. J., Cobo-Marcos, M., Robles, C., Bornstein, B., Salas, C., Lara-Pezzi, E., Alonso-Pulpon, L., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv338 · Cited by 1,174
Mullens, W., Damman, K., Harjola, V.-P., Mebazaa, A., Brunner-La Rocca, H.-P., Martens, P., Testani, J. M., Tang, W. H. W., Orso, F., Rossignol, P., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1369 · Cited by 1,119
Self-citationAdaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure
Cowie, M. R., Woehrle, H., Wegscheider, K., Angermann, C., d’Ortho, M.-P., Erdmann, E., Levy, P., Simonds, A. K., Somers, V. K., Zannad, F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506459 · Cited by 1,107
Fitchett, D., Zinman, B., Wanner, C., Lachin, J. M., Hantel, S., Salsali, A., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Inzucchi, S. E. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv728 · Cited by 907
Crespo-Leiro, M. G., Metra, M., Lund, L. H., Milicic, D., Costanzo, M. R., Filippatos, G., Gustafsson, F., Tsui, S., Barge-Caballero, E., De Jonge, N., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1236 · Cited by 880
Self-citationIntrapericardial Left Ventricular Assist Device for Advanced Heart Failure
Rogers, J. G., Pagani, F. D., Tatooles, A. J., Bhat, G., Slaughter, M. S., Birks, E. J., Boyce, S. W., Najjar, S. S., Jeevanandam, V., Anderson, A. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1602954 · Cited by 758
Koehler, F., Koehler, K., Deckwart, O., Prescher, S., Wegscheider, K., Kirwan, B.-A., Winkler, S., Vettorazzi, E., Bruch, L., Oeff, M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31880-4 · Cited by 739
Self-citationCastaño, A., Narotsky, D. L., Hamid, N., Khalique, O. K., Morgenstern, R., DeLuca, A., Rubin, J., Chiuzan, C., Nazif, T., Vahl, T., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx350 · Cited by 726
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure
Mehra, M. R., Goldstein, D. J., Uriel, N., Cleveland, J. C., Yuzefpolskaya, M., Salerno, C., Walsh, M. N., Milano, C. A., Patel, C. B., Ewald, G. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800866 · Cited by 722
Cleland, J. G. F., Bunting, K. V., Flather, M. D., Altman, D. G., Holmes, J., Coats, A. J. S., Manzano, L., McMurray, J. J. V., Ruschitzka, F., van Veldhuisen, D. J., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx564 · Cited by 659
Self-citationAnti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
Everett, B. M., Cornel, J. H., Lainscak, M., Anker, S. D., Abbate, A., Thuren, T., Libby, P., Glynn, R. J., & Ridker, P. M. (2019) · Circulation · doi:10.1161/circulationaha.118.038010 · Cited by 658
Self-citationMark, D. B., Anstrom, K. J., Sheng, S., Piccini, J. P., Baloch, K. N., Monahan, K. H., Daniels, M. R., Bahnson, T. D., Poole, J. E., Rosenberg, Y., et al. (2019) · JAMA · doi:10.1001/jama.2019.0692 · Cited by 624
Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus
Kato, E. T., Silverman, M. G., Mosenzon, O., Zelniker, T. A., Cahn, A., Furtado, R. H. M., Kuder, J., Murphy, S. A., Bhatt, D. L., Leiter, L. A., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040130 · Cited by 557
Exercise-based cardiac rehabilitation for adults with heart failure
Long, L., Mordi, I. R., Bridges, C., Sagar, V. A., Davies, E. J., Coats, A. J., Dalal, H., Rees, K., Singh, S. J., & Taylor, R. S. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003331.pub5 · Cited by 547
Self-citationSolomon, S. D., Claggett, B., Lewis, E. F., Desai, A., Anand, I., Sweitzer, N. K., O'Meara, E., Shah, S. J., McKinlay, S., Fleg, J. L., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv464 · Cited by 532
Declining Risk of Sudden Death in Heart Failure
Shen, L., Jhund, P. S., Petrie, M. C., Claggett, B. L., Barlera, S., Cleland, J. G. F., Dargie, H. J., Granger, C. B., Kjekshus, J., Køber, L., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609758 · Cited by 508
Self-citationIntravenous Iron in Patients Undergoing Maintenance Hemodialysis
Macdougall, I. C., White, C., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., McMurray, J. J. V., Murray, H., Tomson, C. R. V., Wheeler, D. C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1810742 · Cited by 502
Self-citationCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program
Rådholm, K., Figtree, G., Perkovic, V., Solomon, S. D., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Barrett, T. D., Shaw, W., Desai, M., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034222 · Cited by 488
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
Damman, K., Gori, M., Claggett, B., Jhund, P. S., Senni, M., Lefkowitz, M. P., Prescott, M. F., Shi, V. C., Rouleau, J. L., Swedberg, K., et al. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.02.004 · Cited by 456
Structured telephone support or non-invasive telemonitoring for patients with heart failure
Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D., & Cleland, J. G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007228.pub3 · Cited by 453
Self-citationPitt, B., Anker, S. D., Bushinsky, D. A., Kitzman, D. W., Zannad, F., Huang, I.-Z., & on behalf of the PEARL-HF Investigators (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq502 · Cited by 438
Self-citationLund, L. H., Claggett, B., Liu, J., Lam, C. S., Jhund, P. S., Rosano, G. M., Swedberg, K., Yusuf, S., Granger, C. B., Pfeffer, M. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1149 · Cited by 430
Self-citationvan Veldhuisen, D. J., Ponikowski, P., van der Meer, P., Metra, M., Böhm, M., Doletsky, A., Voors, A. A., Macdougall, I. C., Anker, S. D., Roubert, B., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027497 · Cited by 423
Self-citationOuwerkerk, W., Voors, A. A., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Lang, C. C., ter Maaten, J. M., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx026 · Cited by 404
Self-citationVan Spall, H. G. C., Rahman, T., Mytton, O., Ramasundarahettige, C., Ibrahim, Q., Kabali, C., Coppens, M., Brian Haynes, R., & Connolly, S. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.765 · Cited by 381
Wachter, R., Senni, M., Belohlavek, J., Straburzynska-Migaj, E., Witte, K. K., Kobalava, Z., Fonseca, C., Goncalvesova, E., Cavusoglu, Y., Fernandez, A., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1498 · Cited by 354
Seferovic, J. P., Claggett, B., Seidelmann, S. B., Seely, E. W., Packer, M., Zile, M. R., Rouleau, J. L., Swedberg, K., Lefkowitz, M., Shi, V. C., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30087-6 · Cited by 352
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease
Zannad, F., Anker, S. D., Byra, W. M., Cleland, J. G. F., Fu, M., Gheorghiade, M., Lam, C. S. P., Mehra, M. R., Neaton, J. D., Nessel, C. C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1808848 · Cited by 345
Self-citationEstep, J. D., Starling, R. C., Horstmanshof, D. A., Milano, C. A., Selzman, C. H., Shah, K. B., Loebe, M., Moazami, N., Long, J. W., Stehlik, J., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.075 · Cited by 343
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: PRIME Study
Kang, D.-H., Park, S.-J., Shin, S.-H., Hong, G.-R., Lee, S., Kim, M.-S., Yun, S.-C., Song, J.-M., Park, S.-W., & Kim, J.-J. (2019) · Circulation · doi:10.1161/circulationaha.118.037077 · Cited by 340
Jonkman, N. H., Westland, H., Groenwold, R. H. H., Ågren, S., Atienza, F., Blue, L., Bruggink-André de la Porte, P. W. F., DeWalt, D. A., Hebert, P. L., Heisler, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.018006 · Cited by 317
Self-citation(1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015339 · Cited by 296
Wearable Cardioverter–Defibrillator after Myocardial Infarction
Olgin, J. E., Pletcher, M. J., Vittinghoff, E., Wranicz, J., Malik, R., Morin, D. P., Zweibel, S., Buxton, A. E., Elayi, C. S., Chung, E. H., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800781 · Cited by 285
Abraham, W. T., Kuck, K.-H., Goldsmith, R. L., Lindenfeld, J., Reddy, V. Y., Carson, P. E., Mann, D. L., Saville, B., Parise, H., Chan, R., et al. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.04.010 · Cited by 273
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
Judge, D. P., Heitner, S. B., Falk, R. H., Maurer, M. S., Shah, S. J., Witteles, R. M., Grogan, M., Selby, V. N., Jacoby, D., Hanna, M., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.012 · Cited by 263
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure
Kotecha, D., Flather, M. D., Altman, D. G., Holmes, J., Rosano, G., Wikstrand, J., Packer, M., Coats, A. J. S., Manzano, L., Böhm, M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.001 · Cited by 261
Self-citationKomajda, M., Cowie, M. R., Tavazzi, L., Ponikowski, P., Anker, S. D., & Filippatos, G. S. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.887 · Cited by 259
Self-citationStructured telephone support or non-invasive telemonitoring for patients with heart failure
Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D., & Cleland, J. G. F. (2017) · Heart · doi:10.1136/heartjnl-2015-309191 · Cited by 239
Self-citationEfficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF
Jhund, P. S., Fu, M., Bayram, E., Chen, C.-H., Negrusz-Kawecka, M., Rosenthal, A., Desai, A. S., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv330 · Cited by 229
Böhm, M., Young, R., Jhund, P. S., Solomon, S. D., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw570 · Cited by 219
Desai, A. S., Vardeny, O., Claggett, B., McMurray, J. J. V., Packer, M., Swedberg, K., Rouleau, J. L., Zile, M. R., Lefkowitz, M., Shi, V., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2016.4733 · Cited by 217
Cardiac amyloidosis: An update on diagnosis and treatment
Donnelly, J. P., & Hanna, M. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84.s3.02 · Cited by 213
Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial
Costanzo, M. R., Ponikowski, P., Javaheri, S., Augostini, R., Goldberg, L., Holcomb, R., Kao, A., Khayat, R. N., Oldenburg, O., Stellbrink, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30961-8 · Cited by 208
Self-citationRosano, G. M. C., Tamargo, J., Kjeldsen, K. P., Lainscak, M., Agewall, S., Anker, S. D., Ceconi, C., Coats, A. J. S., Drexel, H., Filippatos, G., et al. (2018) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvy015 · Cited by 204
Self-citationStarling, R. C., Estep, J. D., Horstmanshof, D. A., Milano, C. A., Stehlik, J., Shah, K. B., Bruckner, B. A., Lee, S., Long, J. W., Selzman, C. H., et al. (2017) · JACC: Heart Failure · doi:10.1016/j.jchf.2017.02.016 · Cited by 194
Taylor, R. S., Walker, S., Smart, N. A., Piepoli, M. F., Warren, F. C., Ciani, O., O'Connor, C., Whellan, D., Keteyian, S. J., Coats, A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1311 · Cited by 187
Self-citationMartens, P., Nijst, P., Verbrugge, F. H., Smeets, K., Dupont, M., & Mullens, W. (2018) · Acta Cardiologica · doi:10.1080/00015385.2017.1351239 · Cited by 181
Self-citationBrignole, M., Pokushalov, E., Pentimalli, F., Palmisano, P., Chieffo, E., Occhetta, E., Quartieri, F., Calò, L., Ungar, A., Mont, L., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy555 · Cited by 178
Guidelines for the diagnosis of heart failure
(1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060992 · Cited by 173
High Prevalence of Iron Deficiency in Patients with Acute Decompensated Heart Failure
Solal, A. C., Damy, T., Terbah, M., Kerebel, S., Baguet, J.-P., Hanon, O., Zannad, F. M., Laperche, T., Leclercq, C., Concas, V., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.139 · Cited by 160
Self-citationCharles‐Edwards, G., Amaral, N., Sleigh, A., Ayis, S. A., Catibog, N., McDonagh, T. A., Monaghan, M. J., Amin-Youssef, G. F., Kemp, G. J., Shah, A. M., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038516 · Cited by 160
Self-citationMichel Komajda, N., Böhm, M., BORER, J. S., Ford, I., Tavazzi, L., Pannaux, M., & Swedberg, K. B. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1234 · Cited by 143
State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis
Singh, V., Falk, R. H., Carli, M. F. D., Kijewski, M. F., Rapezzi, C., & Dorbala, S. (2018) · Journal of Nuclear Cardiology · doi:10.1007/s12350-018-01552-4 · Cited by 135
Simpson, J., Jhund, P. S., Silva‐Cardoso, J., Martinez, F., Mosterd, A., Ramires, F. J. A., Rizkala, A. R., Senni, M., Squire, I. B., Gong, J., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.878 · Cited by 130
Lang, C. C., Smith, K. T., Wingham, J., Eyre, V., Greaves, C. J., Warren, F. C., Green, C., Jolly, K. B., Davis, R., Doherty, P., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019649 · Cited by 127
Okumura, N., Jhund, P. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K. B., Zile, M. R., Solomon, S. D., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003212 · Cited by 123
Branch, K. R., Probstfield, J. L., Eikelboom, J. W., Bosch, J., Maggioni, A. P., Cheng, R. K.-H., Bhatt, D. L., Avezum, Á., Fox, K. A. A., Connolly, S. J., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.039609 · Cited by 108
Müllens, W., Verbrugge, F. H., Nijst, P., Martens, P., Tartaglia, K., Theunissen, E., Bruckers, L. M., Droogné, W., Troisfontaines, P., Damman, K., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1307 · Cited by 103
Self-citationBavendiek, U., Berliner, D., Dávila, L. A., Schwab, J., Maier, L. S., Philipp, S., Rieth, A. J., Westenfeld, R., Piorkowski, C., Weber, K., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1452 · Cited by 95
Self-citationReduced Salt Intake for Heart Failure: A Systematic Review
Mahtani, K. R., Heneghan, C. J., Onakpoya, I., Tierney, S., Aronson, J. K., Roberts, N. W., Hobbs, R. F., & Nunan, D. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.4673 · Cited by 92
Smires, Y. B., Victor, G., Ribes, D., Berry, M., Cognet, T., Méjean, S., Huart, A., Roussel, M., Petermann, A., Roncalli, J. G., et al. (2016) · International journal of cardiac imaging · doi:10.1007/s10554-016-0915-z · Cited by 88
Vardeny, O., Claggett, B. L., Kachadourian, J., Pearson, S. M., Desai, A. S., Packer, M., Rouleau, J. L., Zile, M. R., Swedberg, K. B., Lefkowitz, M. P., et al. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004745 · Cited by 84
Gilotra, N. A., Princewill, O., Marino, B., Okwuosa, I. S., Chasler, J. E., Almansa, J. R., Cummings, A. E., Rhodes, P. S., Chambers, J., Cuomo, K. K., et al. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.10.001 · Cited by 78
What Proportion of Patients with Chronic Heart Failure are Eligible for Sacubitril–Valsartan?
Pellicori, P., Urbinati, A., Shah, P. P., Macnamara, A., Kazmi, S., Dierckx, R., Zhang, J., Cleland, J. G. F., & Clark, A. L. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.788 · Cited by 70
Self-citationGreenberg, B., Neaton, J. D., Anker, S. D., Byra, W. M., Cleland, J. G. F., Deng, H., Fu, M., Police, D. A. L., Lam, C. S. P., Mehra, M. R., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1049 · Cited by 67
Self-citationPitt, B., Bushinsky, D. A., Kitzman, D. W., Ruschitzka, F. T., Metra, M., Filippatos, G. S., Rossignol, P., Mond, C. D., Garza, D., Berman, L., et al. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12265 · Cited by 58
Self-citationPitt, B., Bakris, G. L., Weir, M. R., Freeman, M. W., Lainščak, M., Mayo, M. R., Garza, D., Zawadzki, R., Berman, L., & Bushinsky, D. A. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12292 · Cited by 57
Chen, C., Zhou, X., Zhu, M., Chen, S., Chen, J., Cai, H., Dai, J. M., Xu, X., & Mao, W. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0349-8 · Cited by 54
Transthyretin Cardiac Amyloidosis
Mankad, A. K., & Shah, K. B. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0911-5 · Cited by 50
The year in cardiology 2018: heart failure
Cleland, J. G. F., van Veldhuisen, D. J., & Ponikowski, P. P. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz010 · Cited by 38
Self-citationAtienza, F., Schuurmans, M. J., Groenwold, R. H. H., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/avcy-s335 · Cited by 37
Case Selection for Cardiac Resynchronization in Atrial Fibrillation
Cleland, J. G. F., Keshavarzi, F., Pellicori, P., & Dicken, B. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.001 · Cited by 15
Self-citation
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citation2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
Self-citationAuthors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Self-citation2025 ESC/EACTS Guidelines for the management of valvular heart disease
Praz, F., Borger, M. A., Lanz, J., Marin-Cuartas, M., Abreu, A., Adamo, M., Ajmone Marsan, N., Barili, F., Bonaros, N., Cosyns, B., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf194 · Cited by 1,072
Self-citationAmbrosetti, M., Abreu, A., Corrà, U., Davos, C. H., Hansen, D., Frederix, I., Iliou, M. C., Pedretti, R. F. E., Schmid, J.-P., Vigorito, C., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1177/2047487320913379 · Cited by 965
Self-citation
Metadata
- Authors
- Seferovic, P. M., Ponikowski, P., Anker, S. D., Bauersachs, J., Chioncel, O., Cleland, J. G. F., de Boer, R. A., Drexel, H., Ben Gal, T., Hill, L., Jaarsma, T., Jankowska, E. A., Anker, M. S., Lainscak, M., Lewis, B. S., McDonagh, T., Metra, M., Milicic, D., Mullens, W., Piepoli, M. F., Rosano, G., Ruschitzka, F., Volterrani, M., Voors, A. A., Filippatos, G., & Coats, A. J. S.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-08-30
- Volume
- 21
- Issue
- 10
- Pages
- 1169-1186
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W2945994263
- Cited by
- 611
- References
- 97
- FWCI
- 80.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.